中西医结合治疗功能性便秘的疗效观察

目的探讨小麦纤维素颗粒联合乳果糖口服液治疗功能性便秘的疗效。方法研究对象为我院收治的109例功能性便秘患者并随机分为试验组55例和对照组54例。对照组给予乳果糖口服液治疗,试验组联合小麦纤维素颗粒治疗方法。比较两组的临床疗效。结果两组总有效率分别为96.36%、74.07%,试验组较对照组高,差异显著(P0.05)。结论小麦纤维素颗粒联合乳果糖口服液治疗功能性便秘的临床疗效显著,值得推广。     

莫沙必利、乳果糖联合双歧杆菌治疗老年2型糖尿病功能性便秘110例

目的观察分析110例老年2型糖尿病功能性便秘患者消化内科治疗方法及临床疗效。方法选取110例老年2型糖尿病功能性便秘患者为研究对象,随机将患者分为两组,其中观察组55例给予莫沙必利、乳果糖联合双歧杆菌治疗,对照组55例给予单纯莫沙必利治疗,观察比较两组患者临床疗效、症状改善。结果观察组显效67.27%,有效25.46%,无效7.27%,总有效率为92.73%;对照组显效49.09%,有效21.82%,无效29.09%,总有效率为70.91%。两组数据差异有统计学意义(P0.05)。结论采用莫沙必利、乳果糖联合双歧杆菌三联疗法治疗老年2型糖尿病功能性便秘临床疗效显著,能够有效的改善患者排便困难等临床症状,减少停药后复发率,不良反应较少。     

莫沙必利联合康复新和乳果糖口服液治疗便秘型肠易激综合征临床研究

[目的]探讨莫沙必利联合康复新、乳果糖口服液治疗便秘型肠易激综合征(IBS-C)的临床效果。[方法]选取2011年12月~2013年12月在我院确诊为IBS-C的患者102例。并且随机分成治疗组51例,对照组51例。治疗组给予莫沙必利分散片5mg口服、每日3次,康复新液10ml口服、每日3次,乳果糖口服液30ml晨起空腹口服1次。对照组给予莫沙必利分散片5mg口服、每日3次。疗程均4周,之后进行2组疗效评定,观察2组患者腹痛症状及排便改善情况。[结果]治疗组临床总有效率为90.20%,对照组总有效率66.67%,2组疗效比较有统计学意义(P0.05)。[结论]莫沙必利分散片联合康复新、乳果糖口服液治疗便秘型肠易激综合征(IBS-C)的疗效明显优于对照组,值得临床借鉴。     

老年2型糖尿病功能性便秘患者消化内科治疗方法及临床疗效

目的探讨消化内科方法治疗老年2型糖尿病功能性便秘患者的临床疗效。方法该次研究对象来源于该院门诊2015年2月—2016年2月收治的老年2型糖尿病功能性便秘患者70例,均采用消化内科治疗方法,依据治疗药物分组,其中对照组(n=35)采用莫沙必利治疗,观察组(n=35)基于对照组加用乳果糖口服液、双歧杆菌治疗,比较两组临床疗效、症状改善情况。结果对照组总有效率为71.4%,明显低于观察组91.4%,对比差异有统计学意义(P0.05);观察组治疗后排便困难程度为(0.29±0.06)分,排便频率为(0.32±0.10)分,排便不尽与腹胀腹痛为(0.40±0.12)分,明显低于对照组(P0.05)。结论乳果糖口服液、双歧杆菌联合莫沙必利治疗老年2型糖尿病功能性便秘患者临床疗效优良,值得推广。     

盐酸伐昔洛韦颗粒联合双黄连口服液治疗儿童水痘86例临床疗效观察

目的观察盐酸伐昔洛韦颗粒联合双黄连口服液治疗儿童水痘的临床疗效。方法将该院2016-05~2017-04治疗的水痘患儿86例随机分为对照组与观察组,每组43例。对照组给予盐酸伐昔洛韦颗粒治疗,规格:150 mg/包,5~10 mg/(kg·d),2次/d。观察组在对照组基础上加用双黄连口服液进行治疗,规格10 ml/支(相当于饮片7.5 g),1~3岁10 ml/次,3次/d,4~7岁20 ml/次,3次/d,3 d为一个疗程。两组均治疗3 d。观察并记录两组患儿症状改善时间、疗效及不良反应情况。结果观察组显效20例,有效19例,无效4例。对照组显效9例,有效27例,无效7例。观察组疗效优于对照组(P0.05)。患儿临床症状消失时间明显短于对照组(P0.05)。两组患儿不良反应发生率差异无统计学意义(P0.05)。结论盐酸伐昔洛韦颗粒联合双黄连口服液治疗儿童水痘疗效显著,缩短了临床症状改善时间,适合临床推广应用。     

结肠水疗仪治疗功能性便秘的疗效观察

目的观察结肠水疗对功能性便秘的临床疗效。方法将78例功能性便秘患者随机分为两组，对照组给予饮食和生活习惯指导，加用口服莫沙必利片，观察组在对照组基础上加用结肠水疗仪清洗结肠。结果观察组显效21例（52．5％），有效12例（30％），总有效率82．5％，无效7例（17．5％）：对照组显效14例（36．8％），有效10例（26．3％），总有效率63．1％，无效14例（36．9％）。经统计学处理两组总有效率有明显差异（P〈0．05）。结论结肠水疗是一种对功能性便秘具有疗效确切、舒适安全的治疗方法，值得临床推广应用。     

中西医结合疗法治疗老年功能性便秘的临床研究

目的观察乳果糖口服溶液联合自拟中药治疗老年功能性便秘的疗效。方法将临床上功能性便秘老年患者235例随机分为实验组118例和对照组117例。对照组患者单纯口服乳果糖溶液进行治疗,实验组患者在此治疗基础上加用自拟中药进行治疗,连续用药4周为1个疗程,在治疗结束后比较两组患者的疗效。结果实验组患者的临床治疗总有效率为94.07%,明显高于对照组的76.07%,差异有统计学意义(P0.05)。结论乳果糖口服溶液联合自拟中药治疗老年功能性便秘,具有标本兼治的效果,可有效缓解患者的临床症状,在停药后不易发生复发,值得临床推广应用。     

加味通幽汤治疗不同证型老年性功能性便秘的疗效观察

[目的]加味通幽汤治疗不同证型老年性功能性便秘的疗效观察。[方法]收集60例老年性功能性便秘的患者,随机分为治疗组与对照组,每组各30例。治疗组采用加味通幽汤,每日1剂,分早晚餐前温服;对照组采用乳果糖15ml口服,每日2次。2组治疗4周后,综合评估2组治疗前后的疗效及观察加味通幽汤对不同证型老年性功能性便秘的疗效。[结果]治疗4周后,治疗组与对照组在总体疗效、治疗前后总计分与主症(大便情况)计分及中医证候计分、中医证候疗效的比较上,差异均具有统计学意义(P0.05)。治疗组不同中医证型对疗效的影响比较上,差异无统计学意义(P0.05)。[结论]加味通幽汤治疗老年性功能性便秘比口服乳果糖效果更佳。加味通幽汤对不同证型老年性功能性便秘均具有疗效。     

莫沙必利联合胆石通治疗老年人功能性便秘效果观察

目的探讨莫沙必利联合胆石通治疗老年人功能性便秘的疗效。方法随机选取64例老年人功能性便秘患者(年龄≥60岁),根据患者病情和意愿分为观察组和对照组各32例。观察组采用莫沙必利联合胆石通治疗,对照组采用莫沙比利治疗。治疗2周后进行随访。结果观察组显效26例,有效5例,无效1例;对照组显效12例,有效10例,无效10例。观察组出现轻微腹痛2例,轻度腹泻1例,无皮疹症状;对照组明显腹痛3例,重度腹泻1例,出现皮疹2例。结论莫沙必利联合胆石通治疗老年人功能性便秘疗效肯定,患者依从性较高,值得临床推广。     

乳果糖联合枯草杆菌二联活菌治疗老年慢性功能性便秘的疗效

目的:观察乳果糖联合枯草杆菌二联活菌肠溶胶囊治疗老年慢性功能性便秘的临床疗效及不良反应.方法:采用随机对照的方法对大连医科大学附属第一医院2014-01/2014-12消化内科门诊治疗的老年慢性功能性便秘患者105例随机分为3组.A组(n=35)口服乳果糖+枯草杆菌二联活菌肠溶胶囊;B组(n=35)口服枯草杆菌二联活菌肠溶胶囊;C组(n=35)口服乳果糖;疗程4 wk;记录不良反应,评估疗效,并对有效患者随诊3 mo比较3组患者复发率.结果:治疗4 wk后,3组总有效率分别为88.57%、62.86%、68.57%,A组显著高于B和C两组(P0.05);A组大便次数、性状的缓解情况与B、C组比较,P0.01.A、B、C 3组复发率分别为6.45%、13.64%、12.50%,A组低于B、C组,但差异无统计学意义(P0.05);各组不良反应均较低.结论:乳果糖联合枯草杆菌二联活菌肠溶胶囊治疗老年慢性功能性便秘可提高疗效,不良反应少,安全性好.     

Research and Evaluation of the Influence of the Construction of the Gate and the Influence of the Piston Velocity on the Distribution of Gases into the Volume of the Casting

Distribution of gasses to the cast volume and volume of pores can be maintained within the acceptable limits by means of correct setting of technological parameters of casting and by selection of suitable structure and gating system arrangement. The main idea of this paper solves the issue of suitability of die casting adjustment—i.e., change of technological parameters or change of structural solution of the gating system—with regards to inner soundness of casts produced in die casting process. Parameters which were compared included height of a gate and velocity of a piston. The melt velocity in the gate was used as a correlating factor between the gate height and piston velocity. The evaluated parameter was gas entrapment in the cast at the end of the filling phase of die casting cycle and at the same time percentage of porosity in the samples taken from the main runner. On the basis of the performed experiments it was proved that the change of technological parameters, particularly of pressing velocity of the piston, directly influences distribution of gasses to the cast volume.     

县级以下综合医疗机构医务人员对现代结控知识的认识现状调查

目的本文旨在了解医务人员现代结控知识掌握的现状及培训效果?方法于培训前后进行问卷调查,内容包括:病例发现?结核病诊断及化疗?结果培训前疫情报告和转诊,回答正确者占75.2%?71.7%;对临床表现?查痰和诊断依据,回答正确者占83.5%?42.5%?40.8%;抗痨药物?用药方法?化疗原则?短化方案?短化疗程?治愈标准六项,回答正确者占58%?14.4%?20.8%?9.2%?17%?24.3%?培训后再次调查发现,90%以上医务人员对现代结控基本知识已掌握?结论各级医务人员现代结控知识是很贫乏的,因此,对其进行系统培训是极为必要的,此项工作省时?省力?投入少,可收到事半功倍的效果。     

Preservation of the pylorus and resection of the head of the pancreas

The historical evolution of the pylorus-preservation resection of the head of the pancreas is traced from the first resections early in this century to relative standardization of the operation, to a lowering of the operative mortality, and to an interest in improving nutritional status after resection. There are many theoretical advantages for the function of the upper gastrointestinal tract after pylorus and gastric preservation, such as maintenance of gastric capacitance and equilibration of osmotic pressure in gastric digestants, foodstuff digestion and absorption, and bowel motility. After the pylorus-preserving resection, gastric emptying is normal, pyloric function to prevent duodenal reflux is often normal, and gastric acids and serum levels of duodenal hormones are at normal levels, whereas after standard pancreatoduodenectomy, all of these are often abnormal. No prospective blinded studies have been published comparing nutritional values after the two operative procedures, but evidence is presented of a satisfactory result with regard to gastric capacitance, body weight gain, and lack of postgastrectomy symptoms. An undoubted advantage of the pylorus-preserving feature is a simplification of the operation. These gains are achieved without increase in operative mortality, without increase in the incidence of jejunal ulcer, and without theoretical or actual decrease in value of the procedure as a cancer operation, except in patients with duodenal carcinoma proximal to the ampulla of Vater.     

Preservation of the pylorus in resection of the head of the pancreas

Pylorus preservation has been advocated to decrease the morbidity associated with the classical or standard pancreaticoduodenectomy. The proposed advantages are decreased incidence of peptic ulceration, dumping syndrome, and nutritional problems. However, after an initial period of enthusiasm for the procedure, it is now being found that marginal ulceration at the duodenojejunal anastomosis is encountered with increasing frequency. Delay in gastric emptying occurs frequently, with an overall incidence of 30%. With the availability of better pancreatic enzyme supplements, the current incidence of nutritional problems and weight loss after the standard Whipple procedure is unknown. Whether there is a difference in long-term survival after the two procedures performed for adenocarcinoma of the head of the pancreas is still debatable. A controlled trial is needed to answer many of these questions, and pylorus-preserving pancreaticoduodenectomy should be used cautiously until further data become available.